prof. dr. Piet Ost
- ORCID iD
-
0000-0002-2203-4848
Show
Sort by
-
Authors' reply to : comment on 'Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer'
-
- Journal Article
- A1
- open access
Stage migration on prostate-specific membrane antigen positron emission tomography/computed tomography in comparison to conventional imaging in patients with high-risk prostate cancer referred for radiation therapy : results from the phase 2/3 THUNDER trial
-
Feasibility of randomisation to radical prostatectomy or standard care in patients with metastatic prostate cancer
-
- Journal Article
- A1
- open access
Prognostic value of the circulating tumor DNA fraction in metastatic castration-resistant prostate cancer : results from the ProBio platform trial
-
- Journal Article
- A1
- open access
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy
-
- Journal Article
- A1
- open access
Genomic determinants associated with modes of progression and patterns of failure in metachronous oligometastatic castration-sensitive prostate cancer
-
- Journal Article
- A1
- open access
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints
-
- Journal Article
- A1
- open access
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer : an outcome-adaptive randomized platform trial
-
- Miscellaneous
- open access
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer : an outcome-adaptive randomized platform trial (vol 30, pg 3291, 2024)
-
Adjuvant EBRT for muscle-invasive bladder cancer : phase 2 trial secondary analysis (NCT02397434)